Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Voyager Therapeutics
Biotech
Voyager pauses Alzheimer's program 8 months after unveiling med
Voyager Therapeutics has hit pause on a preclinical Alzheimer’s disease program just eight months after unveiling the asset.
James Waldron
Mar 10, 2026 10:20am
Sanofi's stunning CEO switch—Chutes & Ladders
Feb 13, 2026 8:30am
Voyager jettisons staff, Novartis hands back 2 programs
Dec 17, 2025 4:50pm
Voyager sets sail on neuro research trek with Transition Bio
Nov 10, 2025 5:23pm
Neurocrine hands back 2 CNS gene therapy programs to Voyager
May 7, 2025 7:30am
Voyager's ALS program delayed by search for alternative payload
Feb 11, 2025 10:27am
